VRK1 and glioblastoma: In Glioblastoma, knocking down VRK1 leads to decreased BAF activity, which in turn causes nuclear lobulation, blebbing, and micronucleation, resulting in G2-M arrest and DNA damage occurring as a result of these cellular alterations [12].